|
Market Closed -
Nasdaq
23:00:00 18/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 31.52 USD | -5.71% |
|
-6.11% | - |
| Market Cap | 1.4B 1.22B 1.15B 1.04B 1.96B 134B 1.97B 13.78B 5.32B 68.17B 5.25B 5.13B 219B | P/E 2026 * |
-10.1x | P/E 2027 * | -10.7x |
|---|---|---|---|---|---|
| Enterprise Value | 1.41B 1.23B 1.16B 1.06B 1.98B 136B 1.99B 13.94B 5.38B 68.97B 5.31B 5.19B 222B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
100% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| AVLN | Delayed | |
CBOE
| AVLN | Real-time |
Last Transcript: Avalyn Pharma Inc.
| 1 day | -5.71% | ||
| 1 week | -6.11% | ||
| Current month | -9.24% | ||
| 1 month | -18.89% | ||
| 3 months | +0.22% |
| 1 week | 31.18 |  | 36.42 |
| 1 month | 31.18 | | 39.68 |
| Current year | 24.15 | | 40.17 |
| 1 year | 24.15 | | 40.17 |
| 3 years | 24.15 | | 40.17 |
| 5 years | 24.15 | | 40.17 |
| 10 years | 24.15 | | 40.17 |
| Manager | Title | Age | Since |
|---|---|---|---|
Lyn Baranowski
CEO | Chief Executive Officer | 50 | 14/10/2022 |
Douglas Carlson
DFI | Director of Finance/CFO | 47 | 01/05/2024 |
Howard Lazarus
CTO | Chief Tech/Sci/R&D Officer | 60 | 01/08/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Ketan Patel
BRD | Director/Board Member | 51 | 01/03/2017 |
Tiba Aynechi
BRD | Director/Board Member | 50 | 01/03/2017 |
Lyn Baranowski
BRD | Director/Board Member | 50 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/15/26 A | Free | Director | 31,182 | 0.0703% | ||
| 5/1/26 A | F-Prime, Inc.
| Conversion | Company | -727,585 | 1.4654% | |
| 5/1/26 A | SR One Capital Management LP
| Conversion | Company | 38,914,842 | 87.8200% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.71% | -6.11% | - | - | 1.4B | |
| -0.31% | +5.79% | +48.93% | +97.53% | 70.88B | |
| +0.39% | +2.06% | +40.91% | +78.49% | 62.49B | |
| -3.21% | -7.27% | -17.73% | +351.98% | 26.21B | |
| +0.50% | +7.13% | +29.43% | +15.48% | 26.34B | |
| -2.64% | -0.69% | -0.26% | -11.90% | 24.13B | |
| +0.71% | +8.03% | +27.22% | -13.18% | 20.72B | |
| -1.26% | -7.81% | +169.33% | +302.38% | 15.36B | |
| -0.22% | +3.99% | +44.28% | +173.35% | 14.46B | |
| +0.73% | +1.71% | -7.18% | +886.19% | 14.25B | |
| Average | -1.10% | +0.87% | +37.22% | +208.92% | 27.62B | |
| Weighted average by Cap. | -0.50% | +1.40% | +36.51% | +147.97% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -124M -109M -102M -93.05M -174M -11.94B -175M -1.23B -474M -6.07B -467M -457M -19.53B | -135M -118M -112M -101M -190M -13B -191M -1.34B -516M -6.61B -509M -498M -21.27B |
| Net Debt | 16.4M 14.3M 13.5M 12.26M 22.97M 1.57B 23.06M 162M 62.4M 800M 61.59M 60.23M 2.57B | -442M -386M -364M -331M -620M -42.45B -622M -4.36B -1.68B -21.58B -1.66B -1.63B -69.45B |
Employees
55
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/09/26 | $31.52 | -5.71% | 664,783 |
| 17/09/26 | $33.43 | -3.69% | 317,013 |
| 16/09/26 | $34.71 | +1.25% | 244,455 |
| 15/09/26 | $34.28 | -2.00% | 227,176 |
| 14/09/26 | $34.98 | +4.20% | 494,139 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
31.52USD
Average target price
62.25USD
Spread / Average Target
+97.49%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AVLN Stock
Select your edition
All financial news and data tailored to specific country editions
